Dabigatran Etexilate Capsules 150 mg......

Dabigatran Etexilate Capsules 150 mg
DABIGATREX 150   is an anticoagulant medication, and DABIGATREX 150  is commonly used to reduce the risk of stroke and blood clots in individuals with atrial fibrillation (an irregular heart rhythm) and to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE).

DABIGATREX 150   is a direct thrombin inhibitor. DABIGATREX 150  is an enzyme involved in the blood clotting process. By inhibiting thrombin, dabigatran prevents the formation of blood clots.
DABIGATREX 150  is commonly prescribed to:
Reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE).
Reduce the risk of recurrence of DVT and PE.

DABIGATREX 150   etexilate is typically taken orally as capsules. DABIGATREX 150   important to take the medication as prescribed, and DABIGATREX 150 is often recommended to be taken with a full glass of water. The capsules should not be opened, crushed, or chewed.
DABIGATREX 150  monitoring of renal function is important as the excretion of dabigatran is primarily through the kidneys. Your healthcare provider may adjust the dose based on renal function.
DABIGATREX 150  side effects may include gastrointestinal symptoms such as dyspepsia (indigestion), gastritis, and gastrointestinal bleeding. As with any anticoagulant, there is a risk of bleeding, and severe bleeding can occur.
DABIGATREX 150   can interact with other medications, including those affecting renal function and other anticoagulants. DABIGATREX 150   important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and herbal supplements.
DABIGATREX 150 essential to take dabigatran etexilate exactly as prescribed by your healthcare provider. DABIGATREX 150 you have any concerns, questions, or experience side effects, DABIGATREX 150 crucial to discuss them with your healthcare provider for appropriate guidance. Regular follow-up appointments and monitoring are typically recommended to ensure the medication's effectiveness and to address any potential issues.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:https://www.sterisonline.com/product/dabigatrex-150-133288